Heme Oxygenase-1 As Therapeutic Target for Diabetic Foot Ulcers

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Oct 14

PMID 36233341

Authors

Ermelindo Carreira Leal

Eugenia Carvalho

Affiliations

Soon will be listed here.

Abstract

A diabetic foot ulcer (DFU) is one of the major complications of diabetes. Wound healing under diabetic conditions is often impaired. This is in part due to the excessive oxidative stress, prolonged inflammation, immune cell dysfunction, delayed re-epithelialization, and decreased angiogenesis present at the wound site. As a result of these multifactorial impaired healing pathways, it has been difficult to develop effective therapeutic strategies for DFU. Heme oxygenase-1 (HO-1) is the rate-limiting enzyme in heme degradation generating carbon monoxide (CO), biliverdin (BV) which is converted into bilirubin (BR), and iron. HO-1 is a potent antioxidant. It can act as an anti-inflammatory, proliferative, angiogenic and cytoprotective enzyme. Due to its biological functions, HO-1 plays a very important role in wound healing, in part mediated through the biologically active end products generated by its enzymatic activity, particularly CO, BV, and BR. Therapeutic strategies involving the activation of HO-1, or the topical application of its biologically active end products are important in diabetic wound healing. Therefore, HO-1 is an attractive therapeutic target for DFU treatment. This review will provide an overview and discussion of the importance of HO-1 as a therapeutic target for diabetic wound healing.

Citing Articles

Bone Morphogenetic Protein 7 Improves Wound Healing in Diabetes by Decreasing Inflammation and Promoting M2 Macrophage Polarization.

Da Silva J, Figueiredo A, Tseng Y, Carvalho E, Leal E Int J Mol Sci. 2025; 26(5).

PMID: 40076659 PMC: 11900347. DOI: 10.3390/ijms26052036.

Heme oxygenase-1: potential therapeutic targets for periodontitis.

Lv W, Hu S, Yang F, Lin D, Zou H, Zhang W PeerJ. 2024; 12:e18237.

PMID: 39430558 PMC: 11488498. DOI: 10.7717/peerj.18237.

Effective protective mechanisms of HO-1 in diabetic complications: a narrative review.

Zhang J, Ni P, Song Y, Gao M, Guo X, Zhao B Cell Death Discov. 2024; 10(1):433.

PMID: 39389941 PMC: 11466965. DOI: 10.1038/s41420-024-02205-x.

Virulence characteristics of Gram-positive bacteria isolated from diabetic foot ulcers.

Keogh R, Huyvaert S, Moore G, Horswill A, Doran K FEMS Microbes. 2024; 5:xtae013.

PMID: 38783991 PMC: 11114470. DOI: 10.1093/femsmc/xtae013.

The Metabolic Characteristics of Patients at the Risk for Diabetic Foot Ulcer: A Comparative Study of Diabetic Patients with and without Diabetic Foot.

Li X, Wen S, Dong M, Yuan Y, Gong M, Wang C Diabetes Metab Syndr Obes. 2023; 16:3197-3211.

PMID: 37867628 PMC: 10590077. DOI: 10.2147/DMSO.S430426.

References

Lima C, Pereira-Wilson C, Rattan S . Curcumin induces heme oxygenase-1 in normal human skin fibroblasts through redox signaling: relevance for anti-aging intervention. Mol Nutr Food Res. 2010; 55(3):430-42. DOI: 10.1002/mnfr.201000221. View

Blakytny R, Jude E . The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med. 2006; 23(6):594-608. DOI: 10.1111/j.1464-5491.2006.01773.x. View

Figueiredo A, Leal E, Carvalho E . Protein tyrosine phosphatase 1B inhibition as a potential therapeutic target for chronic wounds in diabetes. Pharmacol Res. 2020; 159:104977. DOI: 10.1016/j.phrs.2020.104977. View

George J, Braun A, Brusko T, Joseph R, Bolisetty S, Wasserfall C . Suppression by CD4+CD25+ regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells. Am J Pathol. 2008; 173(1):154-60. PMC: 2438293. DOI: 10.2353/ajpath.2008.070963. View

Long M, Rojo de la Vega M, Wen Q, Bharara M, Jiang T, Zhang R . An Essential Role of NRF2 in Diabetic Wound Healing. Diabetes. 2016; 65(3):780-93. PMC: 4764153. DOI: 10.2337/db15-0564. View

Fu J, Huang J, Lin M, Xie T, You T . Quercetin Promotes Diabetic Wound Healing via Switching Macrophages From M1 to M2 Polarization. J Surg Res. 2019; 246:213-223. DOI: 10.1016/j.jss.2019.09.011. View

Zhang W, Chen L, Xiong Y, Panayi A, Abududilibaier A, Hu Y . Antioxidant Therapy and Antioxidant-Related Bionanomaterials in Diabetic Wound Healing. Front Bioeng Biotechnol. 2021; 9:707479. PMC: 8264455. DOI: 10.3389/fbioe.2021.707479. View

Kim E, Han S, Hwang K, Kim D, Kim E, Hossain M . Antioxidant and Cytoprotective Effects of (-)-Epigallocatechin-3-(3″--methyl) Gallate. Int J Mol Sci. 2019; 20(16). PMC: 6719974. DOI: 10.3390/ijms20163993. View

Hanselmann C, Mauch C, Werner S . Haem oxygenase-1: a novel player in cutaneous wound repair and psoriasis?. Biochem J. 2001; 353(Pt 3):459-66. PMC: 1221590. DOI: 10.1042/0264-6021:3530459. View

10.

Barbagallo I, Galvano F, Frigiola A, Cappello F, Riccioni G, Murabito P . Potential therapeutic effects of natural heme oxygenase-1 inducers in cardiovascular diseases. Antioxid Redox Signal. 2012; 18(5):507-21. DOI: 10.1089/ars.2011.4360. View

11.

Brusko T, Wasserfall C, Agarwal A, Kapturczak M, Atkinson M . An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cells. J Immunol. 2005; 174(9):5181-6. DOI: 10.4049/jimmunol.174.9.5181. View

12.

Rochette L, Zeller M, Cottin Y, Vergely C . Diabetes, oxidative stress and therapeutic strategies. Biochim Biophys Acta. 2014; 1840(9):2709-29. DOI: 10.1016/j.bbagen.2014.05.017. View

13.

Jozkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, Motterlini R . Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid Redox Signal. 2003; 5(2):155-62. DOI: 10.1089/152308603764816514. View

14.

Cepinskas G, Katada K, Bihari A, Potter R . Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. Am J Physiol Gastrointest Liver Physiol. 2007; 294(1):G184-91. DOI: 10.1152/ajpgi.00348.2007. View

15.

Armstrong D, Boulton A, Bus S . Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017; 376(24):2367-2375. DOI: 10.1056/NEJMra1615439. View

16.

Minamino T, Christou H, HSIEH C, Liu Y, Dhawan V, Abraham N . Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci U S A. 2001; 98(15):8798-803. PMC: 37515. DOI: 10.1073/pnas.161272598. View

17.

Kampfer H, Kolb N, Manderscheid M, Wetzler C, Pfeilschifter J, Frank S . Macrophage-derived heme-oxygenase-1: expression, regulation, and possible functions in skin repair. Mol Med. 2001; 7(7):488-98. PMC: 1950056. View

18.

Wagener F, van Beurden H, Von den Hoff J, Adema G, Figdor C . The heme-heme oxygenase system: a molecular switch in wound healing. Blood. 2003; 102(2):521-8. DOI: 10.1182/blood-2002-07-2248. View

19.

Singh A, Kukreti R, Saso L, Kukreti S . Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes. Molecules. 2022; 27(3). PMC: 8840622. DOI: 10.3390/molecules27030950. View

20.

Ram M, Singh V, Kumar D, Kumawat S, Gopalakrishnan A, Lingaraju M . Antioxidant potential of bilirubin-accelerated wound healing in streptozotocin-induced diabetic rats. Naunyn Schmiedebergs Arch Pharmacol. 2014; 387(10):955-61. DOI: 10.1007/s00210-014-1011-3. View